Strategic Life Sciences Advisory

Transforming Regulation into Confident Decisions.

OWLEN helps pharmaceutical and Life Sciences companies assess opportunities, anticipate risks and define a clear path forward in Colombia and Latin America. We bring together regulatory, quality, market and business perspectives to build a complete picture before capital, time or internal resources are committed.

Start a Conversation → Explore How OWLEN Can Help
How we work with clients

Two engagement models for different needs: advancing an opportunity toward market entry or adding specialized capacity to execute priorities.

01Market Entry & Partnerships

From opportunity to execution — with a clear path to market.

For international companies assessing Colombia, and for Colombian or Latin American companies evaluating products, dossiers, manufacturers, licensors or international partnerships, OWLEN can support a specific stage or remain involved throughout the journey. From assessment and strategy definition through dossier preparation, submission, registration management and responses to regulatory requirements, we connect regulatory and technical decisions with Quality, Regulatory Intelligence, Market Access and business perspective to anticipate risks and prepare for market entry. Where needed, support can continue with the product’s regulatory maintenance and evolution throughout its lifecycle.

Discuss an opportunity →
Due Diligence · Regulatory Strategy · Dossier & CMC · Submission & Registration Management · Regulatory Intelligence · Market Access · Local Operating Model · Partnerships · Lifecycle Management
02Regulatory & Quality Support

Specialized capacity when your team’s priorities demand it.

For established Life Sciences teams in Colombia and Latin America, OWLEN expands Regulatory & Quality capacity through outsourcing, in-house or project-based support. We can take ownership of defined workstreams, peak-demand needs or ongoing responsibilities, working within the client’s priorities and processes to sustain execution and reduce operational pressure. This allows internal teams to preserve capacity for portfolio decisions, cross-functional coordination and other priorities that require greater strategic focus.

Discuss Regulatory & Quality support →
Lifecycle Management · Submissions & Variations · Artwork & Promotional Materials · Regulatory Intelligence · GMP–GxP–ISO Quality Systems · CAPA & Change Control · Inspection & GMP Certification Preparation · Pharmacovigilance · Training · Outsourcing / In-house
Situations where OWLEN can add value

Recognizable moments when specialized support matters.

01Entering a market or registering a product

When the pathway, dossier and CMC readiness, quality expectations, Market Access or local operating model need to be clarified before launch or registration.

02Evaluating a product, dossier or international partnership

When a product, manufacturer, licensor or deal looks attractive, but regulatory, technical, quality and commercial risks still need to be tested before commitment.

03Adding Regulatory & Quality capacity

When backlog, lifecycle work or a defined project exceeds internal capacity and you need experienced Regulatory or Quality support without building permanent structure.

04Preparing a quality system or site for inspection

When a site, GMP–GxP–ISO quality system or team needs strengthening, remediation or focused readiness for GMP certification or regulatory inspection.

Capabilities for regulatory, technical and commercial decisions.
01Regulatory Affairs
02Market Access
03GMP–GxP–ISO Quality Systems
04CMC & Technical Strategy
05Due Diligence
06Business Development & Commercial Partnerships
Product scope
PharmaceuticalsMedical DevicesCosmeticsDietary SupplementsFood & Non-Alcoholic BeveragesAlcoholic Beverages
How we assess an opportunity

The regulatory path is only part of the decision.

Dossier and CMC readiness, quality systems, local requirements, market conditions and the commercial model can alter the same opportunity. OWLEN evaluates them together, at the depth the decision requires.

Science & CMC

Are the dossier and CMC package ready for the regulatory pathway?

We assess formulation, manufacturing, analytical methods, stability, specifications and other CMC dependencies against the requirements of the intended submission and target market.

Dossier and CMC readiness
How OWLEN works
01 / Context

See Further.

Understand the context, pathway and dependencies shaping feasibility and timing.

02 / Assessment

Decide Smarter.

Evaluate evidence, readiness, risks and trade-offs before committing resources.

03 / Execution

Move Forward.

Turn the assessment into clear priorities, ownership and next actions.

Start a conversation

Have a product, quality, dossier or market decision to work through?Let's review it.

Share the context, where you are in the process and the decision you need to make. We can help identify the relevant gaps, implications and next step.

Contact OWLEN →